Literature DB >> 2379324

Elevated transcription of heat shock protein gene in scleroderma fibroblasts.

Y Deguchi1, N Shibata, S Kishimoto.   

Abstract

Scleroderma is a systemic disorder characterized by fibrosis, which affects skin, lung, kidney and other organs. Heat shock protein (hsp) (70 kD) has been implicated as an essential element of cell function in cell growth and differentiation. To study the molecular basis of intracellular events in scleroderma fibroblasts, we compared the expression of hsp 70 gene in scleroderma and normal control fibroblasts by nuclear run on transcription assay and Northern blot assay. We show that scleroderma fibroblasts express more than eight times higher level of hsp 70 transcription in normal control fibroblasts at quiescent conditions in the absence of serum. After stimulation with serum, the transcription level of the hsp 70 gene is similar in scleroderma and normal control fibroblasts. Therefore, our results indicate an alteration/activation of intracellular events in scleroderma fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379324      PMCID: PMC1535011          DOI: 10.1111/j.1365-2249.1990.tb05297.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.

Authors:  M Trojanowska; L T Wu; E C LeRoy
Journal:  Oncogene       Date:  1988-10       Impact factor: 9.867

2.  Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.

Authors:  J C Reed; Y Tsujimoto; J D Alpers; C M Croce; P C Nowell
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  Varying patterns of protein synthesis in Drosophila during heat shock: implications for regulation.

Authors:  S Lindquist
Journal:  Dev Biol       Date:  1980-06-15       Impact factor: 3.582

6.  Altered expression of heat shock proteins in embryonal carcinoma and mouse early embryonic cells.

Authors:  M Morange; A Diu; O Bensaude; C Babinet
Journal:  Mol Cell Biol       Date:  1984-04       Impact factor: 4.272

Review 7.  The immunopathology of progressive systemic sclerosis (PSS).

Authors:  D C Haynes; M E Gershwin
Journal:  Semin Arthritis Rheum       Date:  1982-02       Impact factor: 5.532

8.  Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases.

Authors:  A J Barnett
Journal:  Med J Aust       Date:  1978-08-12       Impact factor: 7.738

9.  Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.

Authors:  P F Piguet; M A Collart; G E Grau; Y Kapanci; P Vassalli
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.

Authors:  A Granelli-Piperno; L Andrus; R M Steinman
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  2 in total

1.  Interleukin-33 potentiates bleomycin-induced lung injury.

Authors:  Irina G Luzina; Pavel Kopach; Virginia Lockatell; Phillip H Kang; Ashish Nagarsekar; Allen P Burke; Jeffrey D Hasday; Nevins W Todd; Sergei P Atamas
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

2.  Systemic sclerosis biomarkers detection in the secretome of TGFβ1-activated primary human lung fibroblasts.

Authors:  Ryan T Kendall; Ludivine Renaud; John E Baatz; Maya Malaab; Xinh-Xinh Nguyen; Carol A Feghali-Bostwick
Journal:  J Proteomics       Date:  2021-04-27       Impact factor: 3.855

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.